-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on United Therapeutics, Raises Price Target to $687

Benzinga·07/23/2026 18:47:53
Listen to the news
JP Morgan analyst Jessica Fye maintains United Therapeutics (NASDAQ:UTHR) with a Overweight and raises the price target from $685 to $687.